MAP Master Amino Acid Pattern^® Tablets

Versioni stampabili: italiano, inglese, spagnolo

DESCRIPTION

MAP™ is a dietary protein substitute that provides the MAP Master Amino Acid Pattern® (U.S. Patent No. 5,132,113) a unique pattern of essential amino acids in a highly purified, free, crystalline form. After oral ingestion, MAP™ is rapidly utilized. MAP™ does not require the aid of peptidases and therefore is absorbed within 23 minutes through the first 100 cm of functional small intestine. MAP™ does not provide any fecal residue. MAP™ is amphoteric. MAP™ is supplied in tablets of 1,000 mg for oral administration. Each tablet of MAP™ contains only the active ingredient MAP™. MAP™ contains no inactive ingredients.

COMPOSITION

MAP™, provides the MAP Master Amino Acid Pattern® (U.S. Patent No. 5,132,113) a unique pattern of essential amino acids in a highly purified, free, crystalline form.

CLINICAL STUDIES

The results of comparative, double-blind, triple- and quintuple-crossover Net Nitrogen Utilization (NNU) clinical studies have shown that the subjects, while taking MAP™, as a dietary protein substitute, achieved a body’s 99% NNU. This means that 99% of MAP’s constituent amino acids followed the anabolic pathway, thus acting as precursor of body’s protein synthesis. By comparison, the most nutritious dietary proteins provide an average of only 32% NNU. Hence, MAP™ is more nutritious than dietary proteins. This has been confirmed by the fact that during the studies, each subject body’s nitrogen balance was maintained in equilibrium by taking MAP™ as a sole and total substitute of dietary proteins in a dosage of only 400 mg/kg/day (ideal weight) which provided less than 2 kcal/day ( 1 g MAP™ = 0.04 kcal). The studies results have also shown that 1% of MAP’s constituent amino acids followed the catabolic pathway, thus releasing only 1% of nitrogen catabolites and energy. By comparison dietary proteins release an average of 68% nitrogen catabolites and energy. These facts evidence that MAP™ is safer than dietary proteins and provides the lowest amount of energy in comparison to any dietary protein.

To illustrate: when a dietary protein is digested, it releases its constituent amino acids into the small intestine where they are absorbed. Then, those amino acids can follow either the anabolic pathway or the catabolic pathway (Fig. I).

Figure I. Dietary Protein Metabolism

When dietary amino acids follow the anabolic pathway, they act as precursors for the body's protein synthesis (BPS), thus becoming the body's constituent proteins. Throughout the anabolic pathway amino acids do not release any nitrogen catabolites or energy (Fig. II).

Figure II. The Protein Metabolism Anabolic Pathway

On the other hand, when dietary amino acids follow the catabolic pathway, they act only as a source of energy and not as precursors of body’s proteins synthesis (BPS). Throughout the catabolic pathway, amino acids do release nitrogen catabolites and energy (Fig. III).

Figure III. The Protein Metabolism Catabolic Pathway

INDICATIONS AND USAGE

MAP™ is indicated as a safe and effective substitute for dietary proteins.

ADVERSE REACTIONS

No adverse reactions have been reported.

OVERDOSAGE

No adverse reactions have been reported.

DOSAGE AND ADMINISTRATION

MAP™ should be administered with food. MAP™ in a dosage of 400mg/kg/day (ideal weight) has been shown to be adequate as a sole and total substitute of dietary proteins to maintain the body’s nitrogen balance in equilibrium. To calculate the MAP™ dosage necessary to substitute dietary proteins, apply the following:

For instance, to calculate the dosage of MAP™ necessary to substitute 10 g of dietary proteins, proceed as follows:

1. MAP™ dosage = (Dietary Proteins x 0.4) g
2. MAP™ dosage = (10 x 0.4) g
3. MAP™ dosage = 4 g

Therefore, 4 g (4 tablets) of MAP™ provide a body’s protein synthesis (BPS) equivalent to that provided by at least 10 g of the most nutritious dietary protein.

If administering more than 10 tablets per day, increase dosage gradually. (Not more than 10 tablets should be administered within a two hour period.)

SUPPLY INFORMATION

MAP™ is available in bottles of 100 tablets of 1,000 mg, for oral administration.

Additional professional information on MAP™ is available through the International Nutrition Research Center, Inc.

Le informazioni riportate in questo sito sono da intendersi unicamente a scopo informativo e non sostituiscono il parere del medico o di altri professionisti sanitari. Tali informazioni non vanno utilizzate per diagnosticare o trattare un problema di salute o una malattia, né per la prescrizione di qualsiasi farmaco. In caso di presenza o sospetto di un problema medico, consultare immediatamente il medico o il consulente sanitario. Le informazioni e le affermazioni relative agli integratori alimentari non sono state valutate dalla Food and Drug Administration e non sono fornite a scopo di diagnosi, trattamento cura o prevenzione di qualsiasi malattia. Le recensioni dei clienti sono fornite a scopo unicamente informativo. Tali recensioni rispecchiano solo le esperienze individuali dei recensori e non sono verificate né approvate